JP6006478B2 - Skin circulation promoting cosmetics - Google Patents
Skin circulation promoting cosmetics Download PDFInfo
- Publication number
- JP6006478B2 JP6006478B2 JP2011151533A JP2011151533A JP6006478B2 JP 6006478 B2 JP6006478 B2 JP 6006478B2 JP 2011151533 A JP2011151533 A JP 2011151533A JP 2011151533 A JP2011151533 A JP 2011151533A JP 6006478 B2 JP6006478 B2 JP 6006478B2
- Authority
- JP
- Japan
- Prior art keywords
- skin
- carbon dioxide
- circulation promoting
- blood circulation
- nerol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001737 promoting effect Effects 0.000 title claims description 79
- 239000002537 cosmetic Substances 0.000 title claims description 50
- 230000004087 circulation Effects 0.000 title claims description 24
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 150
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 136
- 239000001569 carbon dioxide Substances 0.000 claims description 75
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 75
- 230000008326 skin blood flow Effects 0.000 claims description 55
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 34
- 239000005792 Geraniol Substances 0.000 claims description 34
- GLZPCOQZEFWAFX-JXMROGBWSA-N Nerol Natural products CC(C)=CCC\C(C)=C\CO GLZPCOQZEFWAFX-JXMROGBWSA-N 0.000 claims description 34
- 229940113087 geraniol Drugs 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 230000017531 blood circulation Effects 0.000 description 31
- 239000007789 gas Substances 0.000 description 28
- 239000000499 gel Substances 0.000 description 28
- 238000011156 evaluation Methods 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 11
- 229910052782 aluminium Inorganic materials 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 235000019645 odor Nutrition 0.000 description 8
- 210000000245 forearm Anatomy 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000006210 lotion Substances 0.000 description 6
- 239000002304 perfume Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 230000002459 sustained effect Effects 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- -1 for example Substances 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000003915 liquefied petroleum gas Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 235000002568 Capsicum frutescens Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 235000017663 capsaicin Nutrition 0.000 description 2
- 229960002504 capsaicin Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 229910001873 dinitrogen Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 210000004761 scalp Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical compound OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229940026110 carbon dioxide / nitrogen Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- TVACALAUIQMRDF-UHFFFAOYSA-N dodecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCOP(O)(O)=O TVACALAUIQMRDF-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- UFRKOOWSQGXVKV-UHFFFAOYSA-N ethene;ethenol Chemical compound C=C.OC=C UFRKOOWSQGXVKV-UHFFFAOYSA-N 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 229960004585 etidronic acid Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VUYXVWGKCKTUMF-UHFFFAOYSA-N tetratriacontaethylene glycol monomethyl ether Chemical compound COCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO VUYXVWGKCKTUMF-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、皮膚の血流量を持続的に増大させる血行促進化粧料に関する。 The present invention relates to a blood circulation promoting cosmetic that continuously increases blood flow in the skin.
皮膚の血行を促進することは、身体の健康と美容にとって大変有益であり、身体の新陳代謝の促進や、肌のくすみ防止、皮膚組織への栄養と水分の供給等、その効果・効能及び応用分野は計り知れない。例えば、皮膚血流量を増加させて、冷え性や肩こり等の血液循環不調による症状等を安全かつ効果的に改善する方法が知られている(特許文献1)。また血行促進剤を毛根に浸透させ、血管を拡張することによって毛髪の生成が促進されることも知られている(特許文献2)。 Promoting blood circulation in the skin is very beneficial for physical health and beauty. Its effects, efficacy and application fields such as promotion of body metabolism, prevention of skin dullness, supply of nutrients and moisture to skin tissue, etc. Is immeasurable. For example, a method is known in which skin blood flow is increased to safely and effectively improve symptoms caused by poor blood circulation such as coldness and stiff shoulders (Patent Document 1). It is also known that the production of hair is promoted by infiltrating the hair root with a blood circulation promoter and dilating blood vessels (Patent Document 2).
一方、血行促進剤としては、カプサイシン或いはカプサイシンを含有する唐辛子末、唐辛子エキス等の数多くのものが報告されており、なかでも、テルピネオールやリナロール、ゲラニオール等のテルペンは、皮膚の血行促進作用を発現し得る上、皮膚刺激性が低いという利点を有することも知られている(特許文献3)。また、炭酸ガスを含有させることによっても、皮膚の血行を促進させることは可能であり、香料としてゲラニオール等も添加することができる(特許文献4)。 On the other hand, many blood circulation promoters such as capsaicin or capsaicin-containing chili powder, chili extract, etc. have been reported. In addition, it is also known to have an advantage of low skin irritation (Patent Document 3). Moreover, it is possible to promote the blood circulation of the skin also by containing carbon dioxide gas, and geraniol etc. can be added as a fragrance | flavor (patent document 4).
しかしながら、皮膚の血行促進作用をもたらす化粧料を得るにあたり、その有効成分としてゲラニオールやネロールのような香料を配合する場合、充分な皮膚血行促進作用が発現する濃度範囲とする必要があるものの、こうした濃度範囲では香料本来の特有の匂いが強くなる傾向にある。また、皮膚の血行促進作用をもたらす化粧料を得るにあたり、その有効成分として炭酸ガスを含有させた場合、皮膚に適用後、炭酸ガスは速やかに大気中に放散され或いは生体中で代謝されてしまうため、皮膚血行促進時間の持続性を充分に図ることができないおそれがある。 However, in order to obtain a cosmetic that brings skin blood circulation promoting action, when a fragrance such as geraniol or nerol is added as an active ingredient, it is necessary to make the concentration range that exhibits sufficient skin blood circulation promoting action. In the concentration range, the inherent odor of the fragrance tends to increase. In addition, when carbon dioxide is included as an active ingredient in obtaining cosmetics that promote skin blood circulation, carbon dioxide is quickly released into the atmosphere or metabolized in the living body after application to the skin. Therefore, there is a possibility that the sustainability of the skin circulation promotion time cannot be sufficiently achieved.
したがって、本発明の課題は、皮膚の血行促進作用を充分に発現しつつ、その作用を持続的に保持し、皮膚刺激性が低い上に使用時における匂いが不快でない皮膚血行促進化粧料を提供することにある。 Accordingly, an object of the present invention is to provide a skin circulation promoting cosmetic that sufficiently exhibits the blood circulation promoting action of the skin, maintains the action continuously, has low skin irritation, and does not have an unpleasant odor during use. There is to do.
そこで本発明者らは、不快な匂いを低減するためにゲラニオールやネロールの濃度を低めつつ、良好な皮膚の血行促進作用を持続的に発現できる皮膚血行促進化粧料を開発すべく種々検討した結果、特定量の炭酸ガスと低濃度のゲラニオール又はネロールとを併用したところ、これらゲラニオールやネロール単独では皮膚血行促進作用が極めて弱い、或いは皮膚血行促進作用が認められないような低含有量としながらも、良好な皮膚の血行促進持続作用を発現し、炭酸ガスを単独で含有させただけでは認められない優れた皮膚の血行促進作用の持続性を発揮し得る皮膚血行促進化粧料が得られることを見出した。 Therefore, the present inventors have conducted various studies to develop skin circulation promoting cosmetics capable of continuously expressing good blood circulation promoting action while reducing the concentration of geraniol and nerol in order to reduce unpleasant odors. When a specific amount of carbon dioxide gas is used in combination with a low concentration of geraniol or nerol, the geraniol or nerol alone has a low content such that the skin blood circulation promoting action is extremely weak or the skin blood circulation promoting action is not recognized. It is possible to obtain a skin circulation promoting cosmetic that exhibits a good skin circulation promoting effect and that can exhibit an excellent skin circulation promoting effect that cannot be recognized only by containing carbon dioxide alone. I found it.
すなわち、本発明は、炭酸ガスを100〜20000ppm含有し、かつゲラニオール又はネロールを0.001〜0.5質量%含有する皮膚血行促進化粧料を提供するものである。 That is, the present invention provides a skin blood circulation promoting cosmetic containing 100 to 20000 ppm of carbon dioxide and 0.001 to 0.5% by mass of geraniol or nerol.
本発明によれば、ゲラニオールやネロールをその匂いが気にならない低い含有量としても、炭酸ガスと共に経皮吸収させることによって、良好な皮膚血行促進作用が認められるようになり、さらにこの皮膚血行促進作用を長期に亘り有効に持続させることができる。そのため、極めて高い皮膚血行促進持続効果を得ることが可能であり、持続的に皮膚血流量を高めて使用者の健康や美容に大いに貢献することができる。従って、本発明は皮膚血行促進持続化粧料として、非常に有用である。 According to the present invention, even when geraniol or nerol is contained at a low content where the odor does not matter, percutaneously absorbed together with carbon dioxide gas, a good skin blood circulation promoting action can be recognized, and further this skin blood circulation promotion. The effect can be sustained effectively over a long period of time. Therefore, it is possible to obtain an extremely high effect of promoting skin circulation, and it is possible to contribute to the health and beauty of the user by continuously increasing the skin blood flow. Therefore, the present invention is very useful as a skin blood circulation promoting cosmetic.
以下、本発明について詳細に説明する。
本発明の皮膚血行促進化粧料は、皮膚血行促進化粧料全量中に、炭酸ガスを100〜20000ppm含有する。このような量の炭酸ガスを含有することにより、ゲラニオールやネロールが低含有量であってもゲラニオールやネロールによる皮膚血行促進作用を充分に発現させることができる。しかも、炭酸ガスを単独で含有させると、これが時間の経過とともに大気中に放散され或いは生体中で代謝されてしまい、経時的に充分な皮膚血行促進作用をもたらすことが困難であるところ、本発明の皮膚血行促進化粧料では、ゲラニオールやネロールと相まって、皮膚血行促進作用を長期に亘り大いに発揮させることができる。従って、本発明は、炭酸ガス100〜20000ppmを含有し、かつゲラニオール又はネロールを0.001〜0.5質量%含有する皮膚血行促進化粧料を更に提供するものである。
Hereinafter, the present invention will be described in detail.
The skin blood circulation promoting cosmetic of the present invention contains 100 to 20000 ppm of carbon dioxide in the total amount of the skin blood circulation promoting cosmetic. By containing such an amount of carbon dioxide, the skin blood circulation promoting action by geraniol or nerol can be sufficiently expressed even if the content of geraniol or nerol is low. In addition, when carbon dioxide gas is contained alone, it is diffused into the atmosphere or metabolized in the living body with the passage of time, and it is difficult to bring about a sufficient skin blood circulation promoting function over time. In the skin blood circulation promoting cosmetics, in combination with geraniol and nerol, the skin blood circulation promoting action can be exerted greatly over a long period of time. Therefore, the present invention further provides a skin circulation promoting cosmetic containing carbon dioxide of 100 to 20000 ppm and containing 0.001 to 0.5% by mass of geraniol or nerol.
炭酸ガスは、低含有量のゲラニオール又はネロールの皮膚血行促進作用を高める点、及び炭酸ガス自体による皮膚血行促進作用を充分持続的に発揮させる点から、皮膚血行促進化粧料全量中に、好ましくは150〜18000ppm含有し、より好ましくは400〜10000ppm含有し、さらに好ましくは1500〜2000ppm含有する。 Carbon dioxide gas is preferably included in the total amount of skin circulation promoting cosmetics from the viewpoint of enhancing the skin blood circulation promoting action of geraniol or nerol with a low content and sufficiently exerting the skin blood circulation promoting action of carbon dioxide gas itself. It contains 150-18000 ppm, More preferably, it contains 400-10000 ppm, More preferably, it contains 1500-2000 ppm.
炭酸ガスを皮膚血行促進化粧料に含有させるには、例えば本発明の皮膚血行促進化粧料をシート状に形成する場合、炭酸ガス以外の成分を予め混合溶解後シート状に形成したものと炭酸ガスとをアルミピロー等の二酸化炭素難透過性容器中へ封入することで、炭酸ガスをシート状の皮膚血行促進化粧料に溶存させることが可能である。 For example, when the skin blood circulation promoting cosmetic of the present invention is formed into a sheet, carbon dioxide is mixed with components other than carbon dioxide previously mixed and dissolved into a sheet and carbon dioxide. Is sealed in a carbon dioxide-impermeable container such as an aluminum pillow, so that carbon dioxide gas can be dissolved in the sheet-like skin circulation promoting cosmetic.
また、本発明の皮膚血行促進化粧料をエアゾール容器等に高圧充填する場合、炭酸ガス以外の成分を予め混合溶解したものと、炭酸ガスとを耐圧容器に充填する。炭酸ガス濃度は、充填する炭酸ガスの量、及び併用する噴射ガスとの分圧により調節することができる。常圧系では、炭酸ガス以外の成分を予め混合溶解した後、密閉混合中で炭酸ガスを飽和溶解又は加圧溶解した後に容器に充填することで、或いは混合溶液を容器に充填した後に炭酸ガスを充填し置換し、密閉して保存することで、飽和濃度の炭酸ガスを溶存させることが可能である。 When the skin blood circulation promoting cosmetic of the present invention is filled in an aerosol container or the like at high pressure, a pressure-resistant container is filled with a mixture obtained by mixing and dissolving components other than carbon dioxide in advance and carbon dioxide. The concentration of carbon dioxide can be adjusted by the amount of carbon dioxide to be filled and the partial pressure with the injection gas used together. In the normal pressure system, components other than carbon dioxide gas are mixed and dissolved in advance, and then carbon dioxide gas is saturatedly dissolved or pressurized and dissolved in hermetically mixed, and then filled into the container, or carbon dioxide gas is filled after the mixed solution is filled into the container. It is possible to dissolve the saturated concentration of carbon dioxide gas by filling and replacing with, and sealing and storing.
なお、本発明の皮膚血行促進化粧料は、使用する直前に炭酸ガスを皮膚血行促進化粧料へ溶解させる態様や、アルミピロー等の封入容器やエアゾール容器に封入して予め炭酸ガスを皮膚血行促進化粧料へ溶解させておく、いわゆる使い切り仕様の態様等を採用してもよい。 The skin blood circulation promoting cosmetic of the present invention is a mode in which carbon dioxide gas is dissolved in the skin blood circulation promoting cosmetic immediately before use, or enclosed in an enclosed container such as an aluminum pillow or an aerosol container, and carbon dioxide gas is promoted in advance. You may employ | adopt the aspect of what is called a use specification etc. which are made to melt | dissolve in cosmetics.
本発明の皮膚血行促進化粧料は、皮膚血行促進化粧料全量中に、ゲラニオール又はネロールを0.001〜0.5質量%含有する。一般に、ゲラニオールやネロールを経皮吸収させることによってこれらの皮膚血行促進作用を充分に発揮させるには、0.5質量%を遥かに超える量で含有させる必要がある。しかしながら、本発明の皮膚血行促進化粧料は、炭酸ガスと相まって、ゲラニオール又はネロールを低含有量としても優れた皮膚血行促進作用をもたらすことができるので、ゲラニオールやネロール由来の強いバラ様香気を弱めることが可能である。また、炭酸ガスを単独で含有させるだけでは持続的に皮膚血行促進作用をもたらすのが困難であるところ、ゲラニオール又はネロールを含有することによって、長期に亘り優れた皮膚血行促進作用を持続的に発揮させることができる。 The skin blood circulation promoting cosmetic of the present invention contains 0.001 to 0.5% by mass of geraniol or nerol in the total amount of the skin blood circulation promoting cosmetic. In general, in order to sufficiently exhibit these skin blood circulation promoting effects by transdermally absorbing geraniol and nerol, it is necessary to contain them in an amount far exceeding 0.5% by mass. However, the skin circulation promoting cosmetic composition of the present invention, in combination with carbon dioxide, can provide an excellent skin circulation promoting action even with a low content of geraniol or nerol, thus weakening the strong rose-like aroma derived from geraniol or nerol. It is possible. In addition, it is difficult to bring about a continuous skin blood circulation promoting effect only by containing carbon dioxide alone. By containing geraniol or nerol, a long-term excellent skin blood circulation promoting effect is exhibited. Can be made.
例えば、本発明の皮膚血行促進化粧料をシート状に形成して皮膚に貼付した場合、貼付後7分経過した時点でシートを剥離すると、炭酸ガスは大気中に放散される或いは生体中で代謝されてほとんど存在しない状態となる。すなわち、炭酸ガスを単独で含有させた場合には、この時点で炭酸ガスによる皮膚血行促進作用はほとんど認められなくなる。しかしながら、本発明の皮膚血行促進化粧料は、炭酸ガスと低含有量のゲラニオール又はネロールとを併用することによって相乗的に皮膚血行促進作用が高められ、加えて、シートを剥離した後、さらに7分経過するに至るまで、高い皮膚血行促進作用を発揮し続けることが確認されており、極めて持続性の高い皮膚血行促進作用をもたらすことができるものである。 For example, when the skin blood circulation promoting cosmetic of the present invention is formed into a sheet shape and applied to the skin, carbon dioxide gas is released into the atmosphere or metabolized in the living body when the sheet is peeled off after 7 minutes have elapsed since application. It is in a state that almost does not exist. That is, when carbon dioxide is contained alone, skin blood circulation promoting action by carbon dioxide is hardly recognized at this point. However, the skin circulation promoting cosmetic composition of the present invention is synergistically enhanced by the combined use of carbon dioxide gas and a low content of geraniol or nerol. It has been confirmed that a high skin blood circulation promoting action continues to be exhibited until a minute has elapsed, and an extremely long-lasting skin blood circulation promoting action can be brought about.
ゲラニオール又はネロールの含有量は、ゲラニオールやネロールによる皮膚血行促進作用の向上や持続性を図る点、及び化粧料として適する弱められた匂いを有するに留めつつ化粧料の安定性を確保する点から、皮膚血行促進化粧料全量中に、好ましくは0.005〜0.4質量%であり、より好ましくは0.02〜0.3質量%であり、さらに好ましくは0.06〜0.2質量%である。ゲラニオール及びネロールは、どちらか一方を単独で用いてもよく、双方を共に用いてもよい。なお、ゲラニオール又はネロールを含有させるにあたり、これらを含む植物や精油等を用いることもできる。 The content of geraniol or nerol is intended to improve and maintain the blood circulation promoting effect of geraniol or nerol, and from the point of securing the stability of the cosmetic while retaining a weakened odor suitable as a cosmetic, The total amount of the skin circulation promoting cosmetic is preferably 0.005 to 0.4% by mass, more preferably 0.02 to 0.3% by mass, and still more preferably 0.06 to 0.2% by mass. It is. Either geraniol or nerol may be used alone, or both may be used together. In addition, in containing geraniol or nerol, the plant, essential oil, etc. containing these can also be used.
哺乳類、特にヒトの正常な皮膚のpHは、通常4〜6の範囲にあり、皮膚のpHが変化すると、皮膚の機能が妨げられてしまう。よって本発明の皮膚血行促進化粧料のpHは、良好な皮膚血行促進作用を奏する点で、好ましくは7.5以下、より好ましくは3.5〜6.5であり、さらに好ましくは4.0〜6.0である。かかるpHは、適宜pH調整剤を用いることによって、最終pHが上記範囲内となるように調整すればよい。pH調整剤としては、例えばコハク酸、クエン酸、酒石酸等の有機酸又はこれらの塩、或いはリン酸又はその塩等が好適に使用される。 The normal skin pH of mammals, particularly humans, is usually in the range of 4-6, and changes in the skin pH interfere with skin function. Therefore, the pH of the skin blood circulation promoting cosmetic of the present invention is preferably 7.5 or less, more preferably 3.5 to 6.5, and still more preferably 4.0 in that it exhibits a good skin blood circulation promoting action. ~ 6.0. Such pH may be adjusted by appropriately using a pH adjuster so that the final pH is within the above range. As the pH adjuster, for example, organic acids such as succinic acid, citric acid and tartaric acid or salts thereof, or phosphoric acid or salts thereof are preferably used.
本発明の皮膚血行促進化粧料には、上記有効成分のほか、通常、化粧品や医薬品等で用いられる他の成分、例えば、粉末成分、液体油脂、個体油脂、ロウ、炭化水素油、高級脂肪酸、高級アルコール、合成エステル油、シリコーン、アニオン界面活性剤、カチオン界面活性剤、両性界面活性剤、非イオン界面活性剤、保温剤、水溶性高分子化合物、増粘剤、皮膜剤、紫外線吸収剤、金属イオン封鎖剤、低級アルコール、多価アルコール、糖類、アミノ酸誘導体、有機アミン類、合成樹脂エマルション、皮膚栄養剤、ビタミン類、酸化防止剤、酸化防止助剤、ゲラニオール及びネロール以外の成分の香料、水等を必要に応じて適宜配合することができる。 In addition to the above active ingredients, the skin circulation promoting cosmetic of the present invention is usually used in other cosmetics and pharmaceuticals, for example, powder ingredients, liquid fats, solid fats, waxes, hydrocarbon oils, higher fatty acids, Higher alcohol, synthetic ester oil, silicone, anionic surfactant, cationic surfactant, amphoteric surfactant, nonionic surfactant, heat retention agent, water-soluble polymer compound, thickener, film agent, UV absorber, Sequestering agents, lower alcohols, polyhydric alcohols, sugars, amino acid derivatives, organic amines, synthetic resin emulsions, skin nutrients, vitamins, antioxidants, antioxidant aids, fragrances of ingredients other than geraniol and nerol, Water or the like can be appropriately blended as necessary.
ゲラニオール及びネロール以外の成分を含む香料としては、特に限定されないが、様々な文献、例えば、「合成香料化学と商品知識」、印藤元一著、1996年化学工業日報社刊;「パフューム アンド フレバー ケミカルス(Perfume and Flavor Chemicals)」、ステファンアークタンダー(STEFFENARCTAMDER)著、1969年等の文献に記載された香料等が好適に使用できる。 The fragrance containing ingredients other than geraniol and nerol is not particularly limited, but various documents such as “Synthetic fragrance chemistry and product knowledge”, Motoichi Into, 1996, Chemical Daily, Inc .; “Perfume and Frever Chemicals” (Perfume and Flavor Chemicals) ", Stefan Arctander, 1969, etc., can be suitably used.
本発明の皮膚血行促進化粧料は、皮膚に塗布して使用するのが最適であり、外皮(頭皮を含む)に塗布する化粧料、医薬品、医薬部外品として、その用途は多岐に亘る。例えば、シート状化粧料、クリーム、化粧水、乳液、パック、美容液等のフェーシャル化粧料やスキンケア化粧料、ボディー化粧料、頭皮頭髪化粧料、洗浄料、ジェル、軟膏等として用いることができる。それぞれシート状、液状、乳液状、ペースト状、ゲル状、粉末状、顆粒状、ペレット状等のいずれの形態を呈していてもよい。
また、これら所望の用途に応じ、上記有効成分のほか、その他の成分を適宜選択して配合すればよい。
The skin circulation promoting cosmetic of the present invention is optimally applied to the skin and used as a cosmetic, pharmaceutical, or quasi-drug applied to the outer skin (including the scalp). For example, it can be used as facial cosmetics such as sheet-like cosmetics, creams, lotions, milky lotions, packs, cosmetics, skin care cosmetics, body cosmetics, scalp hair cosmetics, cleaning agents, gels, ointments and the like. Each may take any form such as a sheet, liquid, emulsion, paste, gel, powder, granule, pellet or the like.
Moreover, what is necessary is just to select and mix | blend other components suitably other than the said active ingredient according to these desired uses.
以下、本発明について、実施例に基づき具体的に説明するが、本発明はこれら実施例に限定されるものではない。 EXAMPLES Hereinafter, although this invention is demonstrated concretely based on an Example, this invention is not limited to these Examples.
[実施例1〜6、比較例1〜3]
表1に示す処方に従って未架橋状態の含水ゲル原液を調製した後、各成分を含有するゲルシートを作製した。
[Examples 1-6, Comparative Examples 1-3]
After preparing an uncrosslinked hydrated gel stock solution according to the formulation shown in Table 1, gel sheets containing each component were prepared.
具体的には、まず、グリセリンとプロピレングリコールとの混合液を混練機に投入し、コハク酸水溶液に分散させたカルボキシメチルセルロース、乾燥水酸化アルミニウムゲル、パラオキシ安息香酸メチルの順に添加して、水溶性ゲルを調製した。次いで、得られたゲルにゲラニオール又はネロールを適濃度にて混合し、この未架橋状態のゲルをPET(ポリエチレン)フィルムと不織布とを積層したEVOH(エチレン・ビニルアルコール共重合体)フィルムに挟み込み、ベーカー式アプリケーターによって含水ゲルの厚さが1.5mmとなるように展延した。さらに、50℃で5日間熟成し、含水ゲル層の架橋反応を完了させて、ゲルシートを得た。次いで、得られたゲルシートを正方形(面積25cm2)に型抜きしてアルミピロー中に炭酸ガスと共に封入し、ゲル中に炭酸ガスが溶存するシートを調製し、5日間室温にて保存したものを評価ゲルシートとした。評価ゲルシートのpHは、4.0〜6.0であった。 Specifically, first, a mixed solution of glycerin and propylene glycol is put into a kneader, and added in the order of carboxymethylcellulose dispersed in an aqueous succinic acid solution, dry aluminum hydroxide gel, methyl parahydroxybenzoate, and water-soluble. A gel was prepared. Next, geraniol or nerol is mixed with the obtained gel at an appropriate concentration, and this uncrosslinked gel is sandwiched between EVOH (ethylene / vinyl alcohol copolymer) films in which a PET (polyethylene) film and a nonwoven fabric are laminated, The hydrated gel was spread so as to have a thickness of 1.5 mm by a Baker type applicator. Further, aging was carried out at 50 ° C. for 5 days to complete the crosslinking reaction of the hydrogel layer to obtain a gel sheet. Next, the obtained gel sheet was cut into a square shape (area: 25 cm 2 ), sealed with carbon dioxide in an aluminum pillow, and a sheet in which carbon dioxide was dissolved in the gel was prepared and stored at room temperature for 5 days. An evaluation gel sheet was obtained. The pH of the evaluation gel sheet was 4.0 to 6.0.
なお、1気圧の炭酸ガスは水1gに対して0.878mL溶解するが、この炭酸ガスを質量に換算すると、約0.0018g(20℃、1atm)となる。そこで、本発明において評価に用いる評価ゲルシート(水分活性値(実測):0.985)が全て水で構成されていると仮定した場合、ゲルシート中に含有される炭酸ガス量は、炭酸ガスをアルミピローに常圧にて封入した場合、約1800ppmと見積られる。
得られた評価ゲルシートを用い、下記に示す方法にしたがって各評価を行った。
In addition, although 0.878 mL of carbon dioxide gas at 1 atmosphere is dissolved with respect to 1 g of water, when this carbon dioxide gas is converted into mass, it becomes about 0.0018 g (20 ° C., 1 atm). Therefore, when it is assumed that the evaluation gel sheet (water activity value (actual measurement): 0.985) used for evaluation in the present invention is composed entirely of water, the amount of carbon dioxide contained in the gel sheet is obtained by converting carbon dioxide to aluminum. When sealed in a pillow at normal pressure, it is estimated to be about 1800 ppm.
Each evaluation was performed according to the method shown below using the obtained evaluation gel sheet.
《匂いの評価》
実施例1〜6及び比較例1〜3で得られた各評価ゲルシートが封入されたアルミピローを開封し、速やかに評価ゲルシートを前腕内側部に貼付し、その際における匂いについて被験者に聞き取り調査を行い、下記基準にしたがって評価した。得られた結果を表1に示す。
5:ほとんど匂いがなく、気にならない
4:匂いはあるが心地よい匂いであり、気にならない
3:匂いがあり、若干気にはなるが不快ではない
2:匂いがありやや不快
1:匂いが強く不快
<Odor evaluation>
The aluminum pillow in which each evaluation gel sheet obtained in Examples 1 to 6 and Comparative Examples 1 to 3 is enclosed is opened, and the evaluation gel sheet is quickly applied to the inner side of the forearm, and the subject is asked to investigate the odor at that time. And evaluated according to the following criteria. The obtained results are shown in Table 1.
5: There is almost no smell and I don't mind 4: There is a smell but it's a pleasant smell, I don't care 3: There is a smell, but I'm a little worried, but it's not uncomfortable 2: There is a smell but somewhat uncomfortable 1: The smell Strongly uncomfortable
《皮膚血行促進作用の評価》
実施例1〜6及び比較例1〜3で得られた各評価ゲルシートが封入されたアルミピローを開封して評価ゲルシートを前腕内側部に7分間貼付した後に剥離し、貼付前と7分間貼付して剥離した後にさらに7分経過した時点とのそれぞれの血流量を測定した。血流量は、前腕部の血流をリアルタイム血流画像化装置FLPI(Moor Instruments Ltd.製、Moor FLPI)を用いた。シート剥離後の血流量を、シートを貼付する前の前腕部の皮膚血流を100として、剥離後7分経過した時点の血流量を相対値で示し、皮膚血行促進作用効果及び皮膚血行促進作用の持続性の指標とした。シート貼付前及び貼付して剥離した後に7分経過した時点における血流量の変化は、3回以上行った測定の平均値として示す。また、実施例1〜6及び比較例1〜3で得られた各評価ゲルシートについて、炭酸ガスを溶存しないシートとした場合についても、同様にして評価を行った。得られた結果を図1に示す。
<Evaluation of skin blood circulation promoting effect>
The aluminum pillow in which each evaluation gel sheet obtained in Examples 1 to 6 and Comparative Examples 1 to 3 was encapsulated was opened, the evaluation gel sheet was applied to the inner side of the forearm for 7 minutes, peeled off, and applied for 7 minutes before and after application. Each blood flow was measured after 7 minutes had passed after peeling. For the blood flow volume, the blood flow in the forearm was measured using a real-time blood flow imaging device FLPI (Moor Instruments Ltd., Moor FLPI). The blood flow after peeling the sheet is defined as the blood flow at the time when 7 minutes have elapsed after peeling, with the skin blood flow in the forearm before the sheet is attached as 100, and the blood circulation promoting effect and skin blood circulation promoting effect are shown. As an indicator of sustainability. The change in blood flow before the sheet sticking and at the time when 7 minutes have passed after sticking and peeling is shown as an average value of the measurement performed three times or more. Moreover, about each evaluation gel sheet obtained in Examples 1-6 and Comparative Examples 1-3, also when it was set as the sheet | seat which does not dissolve carbon dioxide, it evaluated similarly. The obtained results are shown in FIG.
表1によれば、実施例1〜6ではその匂いがほとんど気にならないものの、比較例2ではバラ様香気がかなり強く不快と判断された。比較例3に示されるように、ネロールもゲラニオールと同様に匂いがきつく、皮膚化粧料としては不快であると判断された。 According to Table 1, although the smell was hardly worried in Examples 1-6, it was judged that the rose-like fragrance was quite strong and uncomfortable in Comparative Example 2. As shown in Comparative Example 3, it was judged that nerol had an odor as well as geraniol and was uncomfortable as a skin cosmetic.
また、図1によれば、ゲラニオール及びネロールを含有しない比較例1のシートでは、炭酸ガスの有無によらず、血流量はゲルシート貼付前よりも低く、貼付前の95%程度の血流量を示すにすぎない。これは、ゲルシートに含有される水分が皮膚に移行した結果、水の蒸散熱によって皮膚表面温度が低下し、血流量がシート貼付前に比べて減少したためと考えられる。また炭酸ガス自体の皮膚血行促進作用は、シート剥離後7分経過時点では消失してしまい、ゲラニオール及びネロールを含有しない比較例1のシートでは、皮膚血行促進作用の持続性が得られないこともわかる。なお、本評価は、この比較例1の血流量変化を指標とするものであり、シート貼付前の血流量に対し、比較例1におけるシートを貼付して剥離後7分経過した時点の血流量(約95%)を上回る血流量を示した際に、皮膚血行促進作用が認められると定義した。 Moreover, according to FIG. 1, in the sheet | seat of the comparative example 1 which does not contain geraniol and nerol, blood flow volume is lower than before gel sheet sticking regardless of the presence or absence of carbon dioxide gas, and shows a blood flow rate of about 95% before sticking. Only. This is presumably because the moisture contained in the gel sheet transferred to the skin, the skin surface temperature was lowered by the heat of water evaporation, and the blood flow was reduced compared to before the sheet was applied. Further, the skin blood circulation promoting action of carbon dioxide gas disappears after 7 minutes from the peeling of the sheet, and in the sheet of Comparative Example 1 containing no geraniol and nerol, the skin blood circulation promoting action may not be sustained. Recognize. This evaluation uses the change in blood flow of Comparative Example 1 as an index, and the blood flow at the time when 7 minutes have passed since the sheet in Comparative Example 1 was applied to the blood flow before application of the sheet. It was defined that a skin blood circulation promoting action was observed when the blood flow rate exceeded (about 95%).
ゲラニオールを含有させた実施例1〜3について、炭酸ガスを溶存させないシートとして貼付した場合、いずれもはっきりとした皮膚血行促進作用が認められなかった。これに対し、実施例1〜3の炭酸ガスを溶存しているシートを貼付すると、炭酸ガスが溶存していないシートではほとんど認められなかったシート剥離後7分経過時点の皮膚血行促進作用が、はっきりと確認された。したがって、ゲラニオール濃度0.01、0.05、0.1質量%では、炭酸ガスとゲラニオールとによって相乗的に皮膚血行促進作用が高められ、各々単独でははっきりと認められない皮膚血行促進持続作用が明確に確認できるようになることがわかる。 When Examples 1 to 3 containing geraniol were affixed as sheets that do not dissolve carbon dioxide, no clear blood circulation promoting action was observed. On the other hand, when a sheet in which the carbon dioxide gas of Examples 1 to 3 is dissolved is pasted, the skin blood circulation promoting action at the time of 7 minutes after the sheet peeling, which was hardly recognized in the sheet in which the carbon dioxide gas was not dissolved, It was clearly confirmed. Therefore, at geraniol concentrations of 0.01, 0.05, and 0.1% by mass, the skin blood circulation promoting action is synergistically enhanced by carbon dioxide and geraniol, and the skin blood circulation promoting sustained action that is not clearly recognized in each case. You can see clearly.
ネロールを含有させた実施例4〜6について、炭酸ガスを溶存させないシートとして貼付した場合、いずれの条件においてもはっきりとしたシート剥離後7分経過時点の皮膚血行促進作用は認められなかった。これに対し、実施例4〜6の炭酸ガスを溶存しているシートを貼付すると、炭酸ガスが溶存していないシートではほとんど認められなかったシート剥離後7分経過時点の皮膚血行促進作用が、はっきりと確認された。したがって、ネロール濃度0.05、0.1、0.5質量%では、炭酸ガスとネロールとによって相乗的に皮膚血行促進作用が高められ、各々単独でははっきりと認められない皮膚血行促進持続作用が明確に確認できるようになることがわかる。 In Examples 4 to 6 containing nerol, when pasted as a sheet in which carbon dioxide was not dissolved, no clear blood circulation promoting action was observed at 7 minutes after the sheet was peeled off under any condition. On the other hand, when the sheets in which the carbon dioxide gas of Examples 4 to 6 is dissolved are pasted, the skin blood circulation promoting action at the point of 7 minutes after the sheet peeling, which was hardly recognized in the sheet in which the carbon dioxide gas was not dissolved, It was clearly confirmed. Therefore, at nerol concentrations of 0.05, 0.1, and 0.5% by mass, the skin blood circulation promoting action is synergistically enhanced by carbon dioxide and nerol, and the skin blood circulation promoting and sustained action that is not clearly recognized by each alone. You can see clearly.
[実施例7〜8、比較例4]
炭酸ガスとネロールとによって相乗的に高められる皮膚血行促進作用について、表2に示すように、実施例1と同様にしてネロールを0.2質量%配合したゲルシートを調製し、ゲルシートと共にアルミピローに封入する炭酸ガスの濃度を90ppm〜1800ppmとした評価ゲルシートを作製した。なお、炭酸ガス濃度の調整には、炭酸/窒素の混合ガスを用い、炭酸ガス:窒素ガス=5:95(分圧比)又は炭酸ガス:窒素ガス=20:80の混合ガスをアルミピロー内に封入密封することにより行った。
[Examples 7 to 8, Comparative Example 4]
As shown in Table 2, a gel sheet containing 0.2% by mass of nerol was prepared in the same manner as in Example 1 for synergistic enhancement of skin blood circulation enhanced by carbon dioxide and nerol. An evaluation gel sheet in which the concentration of carbon dioxide gas to be sealed was 90 ppm to 1800 ppm was produced. Carbon dioxide / nitrogen mixed gas was used to adjust the carbon dioxide concentration, and a mixed gas of carbon dioxide: nitrogen gas = 5: 95 (partial pressure ratio) or carbon dioxide: nitrogen gas = 20: 80 was placed in the aluminum pillow. This was done by enclosing and sealing.
得られた各評価ゲルシートが封入されたアルミピローを開封して評価ゲルシートを前腕内側部に7分間貼付した後に剥離し、7分後における血流増加作用を比較した。結果を図2に示す。なお、これらの実施例及び比較例における評価ゲルシートのpHは4.0〜6.0であった。 The obtained aluminum pillow in which each evaluation gel sheet was encapsulated was opened, and the evaluation gel sheet was applied to the inner side of the forearm for 7 minutes and then peeled off. The blood flow increasing action after 7 minutes was compared. The results are shown in FIG. The pH of the evaluation gel sheets in these examples and comparative examples was 4.0 to 6.0.
図2によれば、炭酸ガスとネロールとが共存していても、炭酸ガス濃度がそれぞれ360ppm及び1800ppmである実施例7及び8に比べ、炭酸ガス濃度が90ppmの比較例4においては、ほとんど皮膚血行促進作用が認められなかった。 According to FIG. 2, even if carbon dioxide and nerol coexist, compared with Examples 7 and 8 where the carbon dioxide concentrations are 360 ppm and 1800 ppm, respectively, in Comparative Example 4 where the carbon dioxide concentration is 90 ppm, almost skin No blood circulation promoting effect was observed.
以下に、本発明に関する種々の皮膚血行促進化粧料の態様を例示するが、いずれの実施例も優れた皮膚血行促進作用及び皮膚血行促進作用の持続性を発揮し、同時に皮膚刺激性がなく使用性が良好であった。なお、これらの実施例における身体化粧料の製造方法は、それぞれにおける製造方法として一般的に用いられている方法に従った。また、これらの実施例における身体化粧料のpHは4.0〜6.0であった。 Examples of various skin blood circulation promoting cosmetics relating to the present invention will be exemplified below. However, each of the examples exhibits excellent skin blood circulation promoting action and long-lasting skin blood circulation promoting action, and at the same time has no skin irritation. The property was good. In addition, the manufacturing method of the body cosmetics in these Examples followed the method generally used as the manufacturing method in each. Moreover, the pH of the body cosmetics in these examples was 4.0 to 6.0.
[実施例9:化粧水]
質量%
エタノール 3.0
1,3−ブチレングリコール 6.0
グリセリン 5.0
プロピレングリコール 5.0
POE(15)ラウリルエーテル 0.5
ネロール 0.1
防腐剤 適量
精製水 残余
炭酸ガス以外の成分を混合、攪拌して均一とし、所定の量をアルミピローに入れた後に炭酸ガスを封入して皮膚血行促進化粧水(炭酸ガス濃度約1500ppm)を得た。
[Example 9: lotion]
mass%
Ethanol 3.0
1,3-butylene glycol 6.0
Glycerin 5.0
Propylene glycol 5.0
POE (15) lauryl ether 0.5
Nellore 0.1
Preservative appropriate amount
Purified water residue Components other than carbon dioxide were mixed and stirred to be uniform, and after a predetermined amount was placed in an aluminum pillow, carbon dioxide was sealed to obtain skin circulation promoting skin lotion (carbon dioxide concentration of about 1500 ppm).
[実施例10:乳液]
質量%
ステアリン酸 2.5
セチルアルコール 1.5
エタノール 0.5
ワセリン 5.0
ゲラニオール 0.1
プロピレングリコール 3.0
流動パラフィン 10.0
POE(10)モノオレイン酸エステル 2.0
PEG1500 3.0
トリエタノールアミン 1.0
亜硫酸水素ナトリウム 0.01
カルボキシビニルポリマー 0.05
防腐剤 適量
香料 適量
精製水 残余
炭酸ガス以外の成分を混合、攪拌して均一とし、所定の量をアルミピローに入れた後に炭酸ガスを注入して皮膚血行促進乳液(炭酸ガス濃度約1300ppm)を得た。
[Example 10: Latex]
mass%
Stearic acid 2.5
Cetyl alcohol 1.5
Ethanol 0.5
Vaseline 5.0
Geraniol 0.1
Propylene glycol 3.0
Liquid paraffin 10.0
POE (10) monooleate 2.0
PEG 1500 3.0
Triethanolamine 1.0
Sodium bisulfite 0.01
Carboxyvinyl polymer 0.05
Preservative appropriate amount
Perfume
Purified water residue Components other than carbon dioxide were mixed and stirred to be uniform, and after a predetermined amount was placed in an aluminum pillow, carbon dioxide was injected to obtain a skin circulation promoting emulsion (carbon dioxide concentration of about 1300 ppm).
[実施例11:スキンローション]
質量%
エタノール 3.0
乳酸 0.1
プロピレングリコール 2.0
乳酸ナトリウム 0.3
POE(20)硬化ヒマシ油 0.5
ネロール 0.1
防腐剤 適量
香料 適量
精製水 残余
炭酸ガス以外の成分を混合、攪拌して均一とし、所定の量をアルミピローに入れた後に炭酸ガスを注入して皮膚血行促進スキンローション(炭酸ガス濃度約1700ppm)を得た。
[Example 11: Skin lotion]
mass%
Ethanol 3.0
Lactic acid 0.1
Propylene glycol 2.0
Sodium lactate 0.3
POE (20) hydrogenated castor oil 0.5
Nellore 0.1
Preservative appropriate amount
Perfume
Purified water residue Components other than carbon dioxide were mixed and stirred to be uniform, and after a predetermined amount was placed in an aluminum pillow, carbon dioxide was injected to obtain a skin circulation promoting skin lotion (carbon dioxide concentration of about 1700 ppm).
[実施例12:エアゾール]
質量%
ラウリルリン酸 3.9
モノラウリン酸ポリグリセリル 1.0
カルボキシビミニルポリマー 0.1
アクリル酸・メタクリル酸アルキル共重合体 0.1
キサンタンガム 0.1
トリメチルグリシン 4.9
プロピレングリコール 1.6
L−アルギニン 3.0
ニコチン酸dl−α―トコフェロール 1.0
ヒドロキシエタンジホスホン酸 0.1
パラオキシ安息香酸メチル 0.2
ゲラニオール 0.05
香料 適量
精製水 残量
二酸化炭素及び液化石油ガス以外を混合して原液を調製し、その後混合液に全量の1.5%になるような二酸化炭素と全量の1.2%になるような液化石油ガスの混合ガスを耐圧容器に密封して皮膚血行促進用マッサージ化粧料(炭酸ガス濃度約12000ppm)を得た。
[Example 12: Aerosol]
mass%
Lauryl phosphate 3.9
Polyglyceryl monolaurate 1.0
Carboxybiminyl polymer 0.1
Acrylic acid / alkyl methacrylate copolymer 0.1
Xanthan gum 0.1
Trimethylglycine 4.9
Propylene glycol 1.6
L-Arginine 3.0
Nicotinic acid dl-α-tocopherol 1.0
Hydroxyethane diphosphonic acid 0.1
Methyl paraoxybenzoate 0.2
Geraniol 0.05
Perfume
Purified water Remaining carbon dioxide and liquefied petroleum gas other than carbon dioxide and liquefied petroleum gas are prepared to prepare a stock solution, and then the mixed liquid is carbon dioxide to be 1.5% of the total amount and liquefied petroleum gas to be 1.2% of the total amount. The gas mixture was sealed in a pressure-resistant container to obtain a massage cosmetic for promoting skin blood circulation (carbon dioxide concentration of about 12000 ppm).
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011151533A JP6006478B2 (en) | 2011-07-08 | 2011-07-08 | Skin circulation promoting cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011151533A JP6006478B2 (en) | 2011-07-08 | 2011-07-08 | Skin circulation promoting cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013018719A JP2013018719A (en) | 2013-01-31 |
JP6006478B2 true JP6006478B2 (en) | 2016-10-12 |
Family
ID=47690529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011151533A Active JP6006478B2 (en) | 2011-07-08 | 2011-07-08 | Skin circulation promoting cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6006478B2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6195493B2 (en) * | 2013-08-29 | 2017-09-13 | 花王株式会社 | Topical skin preparation |
KR101463759B1 (en) * | 2014-05-19 | 2014-11-21 | (주)코스메디션 | A method of making carbonated cosmetic using supercritical carbon dioxide based liquid absorber |
JPWO2016052580A1 (en) * | 2014-09-30 | 2017-07-27 | 株式会社 Mtg | Liquid cosmetics |
JP2017105724A (en) * | 2015-12-09 | 2017-06-15 | 株式会社オーシンエムエルピー | Adhesive type cold hot gel sheet |
CN110545783B (en) * | 2017-04-04 | 2023-07-14 | 花王株式会社 | Body cosmetics |
KR102655921B1 (en) * | 2017-04-04 | 2024-04-08 | 카오카부시키가이샤 | body cosmetics |
EP3862008A4 (en) | 2018-10-05 | 2022-06-29 | Kao Corporation | Adhesive sheet for affixation to body, housed in container |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06234628A (en) * | 1993-02-09 | 1994-08-23 | Kao Corp | External agent for skin |
JPH1135455A (en) * | 1997-07-18 | 1999-02-09 | Noevir Co Ltd | Collagen production promoter and skin lotion for preventing aging of skin or promoting healing of wound containing the same promoter |
US6689339B1 (en) * | 1997-11-07 | 2004-02-10 | Medion Research Laboratories Inc. | Viscous compositions containing carbon dioxide |
JP3668161B2 (en) * | 2000-09-28 | 2005-07-06 | 株式会社ヒロマイト | Method for producing carbonic acid transdermal composition |
JP3836411B2 (en) * | 2002-08-28 | 2006-10-25 | ポーラ化成工業株式会社 | Foaming cosmetics |
JP4658568B2 (en) * | 2003-11-21 | 2011-03-23 | 花王株式会社 | Body sheet material |
JP5504388B2 (en) * | 2007-11-15 | 2014-05-28 | 株式会社Anbas | Blood circulation promoter |
JP2009191042A (en) * | 2008-02-18 | 2009-08-27 | Pola Chem Ind Inc | Skin external preparation in aerosol form |
TWI530300B (en) * | 2008-04-11 | 2016-04-21 | Kao Corp | Foam-like skin coating agent |
JP2009292740A (en) * | 2008-06-03 | 2009-12-17 | Pola Chem Ind Inc | Cosmetic for blood circulation promotion |
JP2011088930A (en) * | 2011-01-18 | 2011-05-06 | Medion Research Laboratories Inc | Carbon dioxide percutaneous and transmucosal absorption composition |
-
2011
- 2011-07-08 JP JP2011151533A patent/JP6006478B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2013018719A (en) | 2013-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6006478B2 (en) | Skin circulation promoting cosmetics | |
JP5856739B2 (en) | Body cosmetics for blood circulation promotion | |
JP2003055146A (en) | Cosmetic for massage having cool down effect | |
JP2007145771A (en) | Antibacterial agent composition and deodorant agent | |
TWI776879B (en) | body makeup | |
JP2019059696A (en) | Sheet cosmetic | |
ES2924128T3 (en) | deodorant products | |
EP2465485A2 (en) | Liquid shaving preparation | |
JP7117102B2 (en) | Effervescent aerosol composition | |
TWI791506B (en) | body makeup | |
JP2017178787A (en) | Emulsion cosmetic and sheet cosmetic | |
JP2010143884A (en) | Chapped skin improving agent | |
JP2010116376A (en) | Cosmetic | |
CN105250160A (en) | Mineral black clay cleaning mask | |
JP2013227286A (en) | Moisturizing agent and skin external preparation or cosmetic containing the same | |
JP4288480B2 (en) | Antiperspirant / deodorant | |
JP2006176447A (en) | Composition for scalp and hair | |
EP2550955A1 (en) | Emulsion composition | |
JP2009256319A (en) | Cosmetic | |
JP2023126116A (en) | Method for producing asparagus extract-containing cosmetics | |
JP6726502B2 (en) | External composition | |
JP3979497B2 (en) | Sheet pack cosmetic | |
JP2022145011A (en) | Sheet cosmetic | |
JP2021172587A (en) | Oil-in-water type emulsion cosmetic | |
WO2016125771A1 (en) | Composition for external use and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140625 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150630 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160202 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160310 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160906 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160909 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 6006478 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |